In the realm of oncology, advancements in treatment options continually evolve. Evomela, a reformulation of melphalan, plays a crucial role in enhancing chemotherapy’s efficacy. Its introduction marks a significant shift in treating multiple myeloma. Clinicians consider Evomela due to its improved solubility and reduced toxicity, optimizing patient outcomes. This article explores its significance, potential synergies...